Status:
UNKNOWN
Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis
Lead Sponsor:
Minia University
Conditions:
Bacterial Vaginosis
Eligibility:
FEMALE
20-50 years
Phase:
PHASE4
Brief Summary
N-Acetyl cysteine (NAC) is an amino acid with strong antioxidant, mucolytic and antibacterial properties, and is produced within the human body.Its effect in biofilms has been tested in several bacter...
Detailed Description
Bacterial vaginosis (BV) is the most frequent diagnosis made in women with lower genital tract symptoms. It has recently been observed that 90% of subjects with BV show the growth of bacteria in the f...
Eligibility Criteria
Inclusion
- patients complaining bacterial vaginosis and proved to have BV using standard diagnostic methods for BV
- patients with age between 20-50
Exclusion
- Virgins and menstruating patients.
- Recent douching or sexual intercourse.
- Use of systematic or vaginal antimicrobial therapy or any vaginal suppositories or drugs.
- All patients will sign a written consent before starting the treatment
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01841411
Start Date
March 1 2013
End Date
June 1 2013
Last Update
April 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia university hospital for gynecology and obstetrics
Minya, Egypt